Vanda Pharmaceuticals | DETTE

Debt Changement Date
Acadia Pharmaceuticals USD 0 0 2022-06
Acorda Therapeutics USD 176.16M 4.67M 2023-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
Akebia Therapeutics USD 34.68M 7.93M 2023-12
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Anika Therapeutics USD 132K 10K 2022-06
Arrowhead Research USD 263.06M 263.06M 2023-06
AstraZeneca USD 28.58B 1.26B 2023-09
Bluebird Bio USD 0 0 2022-06
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Esperion Therapeutics USD 261.16M 427K 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Heron Therapeutics USD 149.44M 52K 2023-09
Insmed USD 1.18B 7.19M 2023-12
J&J USD 29.92B 15.68B 2023-09
Lexicon Pharmaceuticals USD 99.26M 493K 2023-09
Ligand Pharmaceuticals USD 7K 76.83M 2023-12
Merck USD 34.86B 2.05B 2023-09
Moderna USD 575M 150M 2023-12
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Sangamo BioSciences USD 0 0 2022-06
Takeda JPY 4.68T 67.91B 2023-09
Teva Pharmaceutical Industries USD 19.97B 704M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Veracyte USD 100K 100K 2023-09



Vanda Pharmaceuticals DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.